HCA-7 Colony 29

Cat.No.: CSC-C9447J

Species: Homo sapiens (Human)

Source: Intestine; Colon

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C9447J
Description
The human colon cancer cell line, HCA-7 Colony 29 expresses Cox-2. An interesting feature of this cell line is that it forms polarised epithelial sheets which allows examination of the trafficking and release of biomolecules in vitro. Cyclooxygenases (COXs) are key enzymes in the conversion of arachidonic acid to prostaglandins and other eicosanoids. It has been found that colonic polyps and cancers overexpress Cox-2 and that the inhibition of this enzyme by nonsteroidal anti-inflammatory drugs decreases the risk of colonic neoplasia. This cell line is useful for studying the role of Cox-2 in cancer cell biology and the investigation of colorectal epithelial cell polarity. Imperial College Innovations has stated that this cell line is not to be supplied to commercial organisations.
Species
Homo sapiens (Human)
Source
Intestine; Colon
Recommended Medium
DMEM + 10% FBS + 2mM L-Glutamine + 110mg/L Sodium Pyruvate (NaP)
Disease
Colon Adenocarcinoma
Storage
Liquid Nitrogen (-180 °C).
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Never can cryopreserved cells be kept at -20 °C.
Synonyms
HCA7 colony 29; HCA-7 Colony29; Col 29
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

HCA-7 Colony 29 (HCA-7 Col.29) is an established human colorectal adenocarcinoma cell line derived from a primary colon carcinoma. It is a model system that displays a well-differentiated epithelial tumor phenotype and is used as an in vitro model to study colorectal cancer biology, including signaling pathways associated with inflammation-driven tumorigenesis.

HCA-7 Colony 29 cells are adherent monolayer culture cells with cobblestone-like epithelial morphology and exhibit tight intercellular junctions. The hallmark feature of this cell line is the high constitutive expression of cyclooxygenase-2 (COX-2) and the robust production of prostaglandin E₂ (PGE₂), which mimics the inflammatory signaling observed in colorectal tumors. Additionally, these cells express epithelial markers such as cytokeratins and E-cadherin, indicating a retained epithelial differentiation. HCA-7 Colony 29 is used extensively to study the role of COX-2-prostaglandin signaling in colorectal cancer progression, tumor-associated inflammation, angiogenesis, and immune modulation. It is also a well-established model for the screening of nonsteroidal anti-inflammatory drugs (NSAIDs), selective COX-2 inhibitors, and other anti-cancer or anti-inflammatory agents.

P-Cadherin Knockout Accelerates IEC Wound Healing by Modulating Cell-Matrix Adhesion and Cell Spreading

Inflammatory bowel diseases (IBD) cause recurrent intestinal inflammation, disrupting epithelial homeostasis and potentially leading to colitis-associated colon cancer (CAC). P-cadherin, an adhesion protein upregulated in inflamed mucosa, may play a role in intestinal inflammation and CAC. Naydenov et al. investigated P-cadherin's roles in these processes.

They investigated the role of P-cadherin in modulating intestinal epithelial cell (IEC) migration using HCA-7 Colony 29 (referred hereafter as HCA-7) - and SK-CO15 cells, well-differentiated human colonic carcinoma cell lines. CRISPR-Cas9 was used to knockout P-cadherin in these cell lines. The loss of P-cadherin did not significantly affect cell proliferation but significantly enhanced collective IEC migration in wound healing models (Fig. 1C-F). Live imaging of wounded HCA-7 monolayers showed higher migration velocity in P-cadherin knockout cells compared to controls (Fig. 2A). Individual cell migration analysis revealed increased migrated distance and speed but decreased directionality in P-cadherin-deficient cells (Fig. 2B-E). These findings suggest that P-cadherin directly affects cell motility, crucial for wound healing, rather than indirectly influencing it through junctional remodeling.

Knockout P-cadherin promotes intestinal epithelial cell migration.

Fig. 1. Knockout P-cadherin promotes intestinal epithelial cell migration (Naydenov NG, Lechuga S, et al., 2022).

Analysis of live cell migration of control and P-cadherin-deficient IEC.

Fig. 2. Analysis of live cell migration of control and P-cadherin-deficient IEC (Naydenov NG, Lechuga S, et al., 2022).

.

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products